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Abstract 17 
The health benefits of olive oil are attributed to their bioactive compounds, such as 18 
hydroxytyrosol. Previously, we demonstrated that hydroxytyrosol inhibits angiogenesis in vitro. 19 
The present study aimed to: i) get further insight into the effects of hydroxytyrosol on 20 
extracellular matrix remodeling; and ii) test whether hydroxytyrosol is able to inhibit 21 
angiogenesis ex vivo and in vivo. Hydroxytyrosol induced a shift toward inhibition of 22 
proteolysis in endothelial cells, with decreased expression of extracellular matrix remodeling-23 
enzyme coding genes and increased levels of some of their inhibitors. Furthermore, this work 24 
demonstrated that hydroxytyrosol, at concentrations within the range of its content in virgin 25 
olive oil that can be absorbed from moderate and sustained virgin olive oil consumption, is a 26 
strong inhibitor of angiogenesis ex vivo and in vivo. These results suggest the need for 27 
translational studies to evaluate the potential use of hydroxytyrosol for angio-prevention and 28 
angiogenesis inhibition in clinical setting. 29 
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1. Introduction 36 
The phenolic compounds in extra virgin olive oil are bioactive compounds with well-37 
documented beneficial effects (Fortes, García-Vilas, Quesada & Medina, 2012; Owen et al., 38 
2000) these compounds are not essential in the sense that nutrients are. In fact, the European 39 
Union has authorized a health claim for polyphenols, based on consumption of olive oil 40 
polyphenols, for the protection of blood lipids from oxidative stress ("Commission Regulation 41 
(EU) 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, 42 
other than those referring to the reduction of disease risk and to children’s development and 43 
health. O.J. 2012, L136/1.," 2012). Hydroxytyrosol or 3,4-dihydroxyphenyl ethanol is claimed 44 
to be the most important health-related phenolic compound of virgin olive oil (Lopez de Las 45 
Hazas, Rubio, Kotronoulas, de la Torre, Sola & Motilva, 2015). Along with its cardioprotective 46 
effects (Mnafgui et al., 2015; Samuel, Thirunavukkarasu, Penumathsa, Paul & Maulik, 2008), 47 
beneficial effects of hydroxytyrosol for human health include its antifungal (Zoric et al., 2013), 48 
antidiabetic (Tutino, Orlando, Russo & Notarnicola, 2015; Zheng, et al., 2015), neuroprotective 49 
(De La Cruz, et al., 2015; Gallardo, Madrona, Palma-Valdes, Espartero & Santiago, 2015), anti-50 
inflammatory (Fuccelli, Fabiani, Sepporta & Rosignoli, 2015; Persia, Mariani, Fogal & Penissi, 51 
2014; Silva et al., 2015) and antitumoral (Granados-Principal et al., 2014; Sirianni et al., 2010; 52 
Sun, Luo, & Liu, 2014; Zhao et al., 2014) activities. In 2012, our group added the first 53 
description of hydroxytyrosol as an anti-angiogenic compound able to inhibit several key steps 54 
in the angiogenic process. In fact, we demonstrated that hydroxytyrosol (but not tyrosol) 55 
induced endothelial cell apoptosis and changes in cell cycle distribution as well as inhibiting 56 
endothelial cell proliferation, migration and differentiation into "capillary-like" tubes (Fortes et 57 
al., 2012). Furthermore, that work also identified matrix metalloproteinase 2 (MMP-2) as one of 58 
the molecular targets of the anti-angiogenic action caused by hydroxytyrosol. Since the 59 
publication of that article, additional data have been published regarding the roles of 60 
hydroxytyrosol as an anti-angiogenic compound. Several molecular targets have been identified 61 
contributing to the anti-angiogenic effects of hydroxytyrosol, including inhibition of MMP-9, 62 
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cyclooxygenase 2 and vascular endothelial growth factor receptor-2 (VEGFR-2) 63 
phosphorylation (Lamy, Ouanouki, Beliveau & Desrosiers, 2014; Scoditti et al., 2012; Scoditti 64 
et al., 2014). Furthermore, hydroxytyrosol has been recently shown to have protective effects 65 
against rheumatoid arthritis, an angiogenesis-dependent disease (Silva et al., 2015).  66 
The identification of MMPs as molecular targets for hydroxytyrosol suggests that this 67 
compound can alter extracellular matrix remodeling (Fortes, García-Vilas, Quesada & Medina, 68 
2012; Scoditti et al., 2014), a key step in the angiogenic process. Therefore, the first aim of the 69 
present work was to study the effects of hydroxytyrosol on key extracellular matrix remodeling 70 
enzymes expressed in endothelial cells. On the other hand, in spite of the recent efforts to get 71 
deep insights on the anti-angiogenic potential of hydroxytyrosol there is still no data available 72 
demonstrating its potential inhibitory effects in ex vivo or in vivo models of angiogenesis. The 73 
second aim of this work was to test the anti-angiogenic potential of hydroxytyrosol in the ex 74 
vivo aortic ring and the in vivo CAM angiogenesis models. 75 
 76 
2. Materials and methods 77 
2.1. Chemicals 78 
Supplements and other chemicals not listed in this section were obtained from Sigma 79 
Chemicals Co. (St. Louis MO, USA). Cell culture media, penicillin, streptomycin and 80 
amphotericin were purchased from Biowhittaker (Walkersivlle, MD, USA). Fetal bovine serum 81 
(FBS) and human serum (HS) were products of Harlan-Seralb (Belton, United Kingdom). 82 
Plastics for cell culture were supplied by NUNC (Rockilde, Denmark) and VWR (West Chester, 83 
Pennsylvania, USA). Hydroxytyrosol was supplied by Extrasynthèse (Lyon, France).  84 
 85 
2.2. Cell culture 86 
Most of the procedures described in Materials and methods have been previously used by 87 
our research group for other studies (see, for instance Garcia-Vilas et al. 2013, Martínez-Poveda 88 
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et al. 2013). Bovine aorta endothelial cells (BAEC) were isolated from bovine aortic arches, as 89 
previously described (Gospodarowicz & Moran, 1975), and maintained in Dulbecco´s modified 90 
Eagle´s medium (DMEM) containing glucose (1 g/L), glutamine (2 mM), penicillin (50 91 
IU/mL), streptomycin (50 mg/ L), amphotericin (1.25 mg/L), 10% fetal bovine serum. 92 
 93 
2.3. RNA isolation and purification and cDNA synthesis 94 
Cells at 80% of confluence in 6-well plates were treated with or without 1mM of 95 
hydroxytyrosol for 24 h. After incubation, cells were harvested and washed (PBS). Total RNA 96 
was isolated with the GeneElute Mammalian Total RNA Miniprep Kit (Sigma-Aldrich) 97 
according to the purchaser's instructions. 98 
cDNA synthesis was carried out with the iScript cDNA synthesis kit (BioRad).  99 
 100 
2.4. qPCR 101 
For quantitative RT-PCR (qPCR), total RNA isolation and complementary DNA synthesis 102 
were performed as described above and PCR reactions were done using KAPA SYBR Fast 103 
Master Mix (2x) Universal (KAPA Biosystems) in an Eco Real-Time PCR System. qPCR was 104 
performed in triplicate for each sample in keeping with the manufacturer´s instructions. All 105 
qPCR data were normalized to GAPDH expression (Martínez-Poveda et al. 2013). Primers, 106 
amplicon size, and qPCR conditions for each gene are shown in Table 1.  107 
 108 
2.5. Animals and ethical statement 109 
All experimental procedures with animals were conducted in accordance with the Spanish 110 
Legislation (Real Decreto 53/2013, BOE, 34/-11421, 2013) in compliance with the European 111 
Community Directive 2010/63/EU regulating the use and care of laboratory animals. The 112 
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protocols were approved by the Ethics Committee for Animal Experiments of the University of 113 
Málaga. 114 
 115 
2.6. Ex vivo rat aortic ring assay 116 
Thoracic aortas were removed from 12 week old rats and immediately transferred to a 117 
culture dish containing DMEM. The perioaortic fibroadipodise tissue was carefully removed 118 
with fine microsdissecting forceps and iridectomy scissors paying special attention not to 119 
damage the aortic wall. Afterwards, 1-mm aortic rings were sectioned and embedded in a rat tail 120 
interstitial collagen gel (1.5 mg/mL) prepared by mixing 7.5 volumes of 2 mg/mL collagen, 1 121 
volume of 10x HBBS, 1.5 volumes of 186 mM NaHCO3 and 0.1 volumes of 1 M NaOH to 122 
adjust the pH to 7.4. Collagen gels containing the aortic rings were polymerized in cylindrical 123 
agarose wells and kept in triplicate at 37˚C in 60 mm diameter Petri dishes (bacteriological 124 
polysterene, Falcon, Becton Dickinson, Lincoln Park, New Yersey). Each Petri dish contained 6 125 
mL of MCDB131 medium supplemented with 1% L-glutamine, 25 mM NaHCO3, 100 U/mL 126 
penicillin, 100 µg/mL streptomycin, in presence of hydroxytyrosol or etanol (vehicle).  Cultures 127 
were kept at 37˚C, 5% CO2 in a humidified environment, and photographs were taken after 6, 9 128 
and 14 days. The antiangiogenic response was quantified by microvessel counting according to 129 
published criteria (Nicosia & Ottinetti, 1990). 130 
 131 
2.7. In vivo chorioallantoic membrane (CAM) assay 132 
Fertilized chick eggs were incubated horizontally at 38°C in a humidified incubator, 133 
windowed by day 3 of incubation and processed by day 8. The indicated amount of 134 
hydroxytyrosol was added to a 1% solution of methylcellulose in water, and 10 μL drops of this 135 
solution were allowed to dry on a Teflon-coated surface in a laminar flow hood. Then, the 136 
methylcellulose disks were implanted on the CAMs, and the eggs were sealed with adhesive 137 
tape and returned to the incubator for 48 h (Garcia-Vilas et al. 2013). Negative controls were 138 
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always made with ethanol (vehicle) mixed with methylcellulose. After the reincubation, CAMs 139 
were examined under a stereomicroscope. The assay was scored as positive when two 140 
independent observers reported a significant reduction of vessels in the treated area.  141 
 142 
2.8. Statistical analysis 143 
For all of the assays, at least three independent experiments were carried out. Results are 144 
expressed as means ± SD. Statistical significance was determined by using Student´s paired 145 
simple test. Values of p<0.05 were considered to be significant. 146 
 147 
3. Results 148 
 149 
3.1. Hydroxytyrosol induces changes in the expression levels of genes involved in ECM 150 
remodeling in endothelial cells 151 
To fulfil the first goal of our work, we analyzed by qPCR the effects of 1 mM 152 
hydroxytyrosol treatment of BAEC for 24 h on the expression levels of messenger 153 
corresponding to a number of genes involved in ECM remodeling. The primers, annealing 154 
temperature and amplicon sizes are summarized in Table 1. Table 2 summarizes the qPCR 155 
quantitative data for the 9 tested potential targets. Both MMP-1 and MMP-2 mRNA expression 156 
levels were drastically diminished by hydroxytyrosol, whereas three out of four tissue inhibitors 157 
of metalloproteinases (namely, TIMP-1, -2 and -4) mRNA expression levels were increased 158 
several fold. On the other hand, the mRNA levels for urokinase-type plasminogen activator 159 
(uPA), another ECM remodeling enzyme, were also drastically diminished upon hydroxytyrosol 160 
treatment, whereas the levels of the messenger for its specific receptor (uPAR) increased more 161 
than 20-fold. Finally, we could not detect any signal for plasminogen activator inhibitor 1 (PAI-162 
1) mRNA. 163 
 164 
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3.2. Hydroxytyrosol has a very potent inhibitory effect on the ex vivo rat aortic ring 165 
angiogenesis assay 166 
The second goal of this work was to test the anti-angiogenic potential of hydroxytyrosol in 167 
the ex vivo aortic ring and the in vivo CAM angiogenesis models. Figure 1 clearly shows that 168 
hydroxytyrosol was able to induce very strong inhibitory effects in the ex vivo aortic ring assay, 169 
even at concentrations much lower than those used previously by us to show its in vitro anti-170 
angiogenic effects (Fortes, García-Vilas, Quesada & Medina, 2012). At 0.25 mM 171 
hydroxytyrosol the inhibition of microvessel outgrowth from the aortic rings was complete after 172 
6, 9 and 14 days of incubation. At 0.125 mM hydroxytyrosol we observed outgrowing of 173 
proliferative endothelial cells from the aortic ring but these cells were not forming microvessel 174 
tubes. Furthermore, there were partial inhibitory effects for 62.5 µM hydroxytyrosol. 175 
 176 
3.3. Hydroxytyrosol inhibits in vivo angiogenesis 177 
Figure 2 shows that in untreated, control CAMs, blood vessels form a spatially-oriented and 178 
dense network of vascular structures with progressively smaller diameters as they branch. 179 
Hydroxytyrosol-treated CAMs showed inhibited angiogenesis, as revealed by an inhibition of 180 
new vessel formation within the area covered by the methylcellulose discs, a centrifugal growth 181 
of peripheral vessels, avoiding the treated area, and an overall decrease in vascular density. 182 
Table 3 summarizes the results obtained with the CAM assay. Positive, inhibitory effects were 183 
observed in 90% of eggs treated with 800 nmol of hydroxytyrosol. The inhibition was still 184 
observed in more than half of the CAMs treated with 400 nmol of hydroxytyrosol. For 185 
treatments with 200 and 100 nmol of hydroxytyrosol, 42% and 13% of the eggs scored positive. 186 
No inhibitory effect was observed in eggs treated with 50 nmol of hydroxytyrosol. 187 
 188 
4. Discussion 189 
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As mentioned in the Introduction, a number of very different biological effects have been 190 
shown for hydroxytyrosol, underscoring its preventive and pharmacological potential. Our 191 
group demonstrated for the first time that hydroxytyrosol also behaves as an anti-angiogenic 192 
compound in vitro (Fortes, García-Vilas, Quesada & Medina, 2012). One of the molecular 193 
targets for this effect of hydroytyrosol was the extracellular remodeling enzyme MMP-2, which 194 
plays a key role in the basal membrane destruction needed for the migration and invasion of 195 
proliferative endothelial cells during the angiogenic process (Stetler-Stevenson, 1999). This 196 
result was consistent with the description by another independent research group of the 197 
suppression of MMP-9 expression by hydroxytyrosol in both human endothelial cells (Scoditti, 198 
et al., 2012) and activated human monocytes (Scoditti, et al., 2014). Our qPCR results (Table 2) 199 
indicate that, indeed, hydroxytyrosol seems to have a global stimulating effect on ECM 200 
remodeling by both decreasing the expression levels of genes coding for extracellular matrix 201 
remodeling enzymes (MMP-1, MMP-2, uPA) and increasing the levels of some of their 202 
inhibitors (TIMP-1, -2, and -4).  203 
A particularly important molecular target of hydroxytyrosol is VEGFR-2, since it plays a key 204 
role as a master regulator of the pro-angiogenic phenotype. In fact, it has been shown that 205 
hydroxytyrosol is a very potent inhibitor of the specific autophosphorylation sites  (Tyr951, 206 
Tyr1059, Tyr1175, and Tyr1214) of VEGFR-2, thus inhibiting angiogenesis (Lamy, Ouanouki, 207 
Beliveau, & Desrosiers, 2014). These and other molecular data strongly suggested that 208 
hydroxytyrosol might have protective effects on angiogenesis-dependent diseases. This seems 209 
to be the case for age-related macular degeneration and rheumatoid arthritis (Granner, Maloney, 210 
Antecka, Correa & Burnier, 2013; Silva et al., 2015). Nonetheless, there is still need additional 211 
pre-clinical data showing modulatory effects of hydroxytyrosol beyond the in vitro situation to 212 
boost the interest to test the hydroxytyrosol potential for its clinical use. In this context, both ex 213 
vivo and in vivo assays seem required and useful. To our knowledge, the only available study 214 
showing an additional and indirect evidence of the anti-angiogenic effect of hydroxytyrosol in 215 
vivo was the article showing that hydroxytyrosol suppresses the growth of human hepatocellular 216 
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carcinoma through the inactivation of both AKT and NF-kB pathways (Zhao et al., 2014). In 217 
that article, figure 5C shows a histogram with the quantification of microvessel density in 218 
orthotopic hepatocellular carcinoma tumors stained for the microvessel marker CD31. In the 219 
present work, we have used two very popular pre-clinical angiogenesis assays, namely, 220 
the ex vivo aortic ring assay and the in vivo CAM assay. The ex vivo aortic ring assay 221 
allows for the analysis of cell proliferation, migration, tubule-like formation, microvessel 222 
branching and perivascular recruitment and remodeling (Baker et al., 2012). The CAM assay is 223 
the most frequently used in vivo assay of angiogenesis (Ribatti, 2008). The results obtained to 224 
fulfil the second aim of the present work have contributed to provide clear and remarkable 225 
evidence that, indeed, the anti-angiogenic effects of hydroxytyrosol observed previously in vitro 226 
are strongly confirmed by both ex vivo and in vivo angiogenesis assays carried out in the present 227 
work (Figures 1 and 2, and Table 3).  228 
Interestingly, the effects described in the present work were obtained with hydroxytyr0sol 229 
doses within the range described previously as absorbed from a sustained and moderate dose of 230 
virgin olive oil, similar to that corresponding to its daily intake in a typical Mediterranean diet 231 
(Miró-Casas et al., 2003). 232 
The results presented in this work can be considered a step further toward translational 233 
studies to be carried out in the near future regarding the potential use of hydroxytyrosol in 234 
angioprevention and for the pharmacological inhibition of angiogenesis. 235 
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Table 1. Primers used for qPCR with indication of their respective annealing temperatures 361 
and amplicon sizes. 362 
363 
Gene Primers 
Annealing  
temperature 
(°C) 
Amplicon 
size (bp) 
MMP-1 
Forward: gacttagtccagaaatacctg 
60 121 
Reverse: caaagaattcctgcatttgc 
MMP-2 
Forward: gacatacatctttgctggagac 
60 200 
Reverse: acgctcttcagactttggttct 
TIMP-1 
Forward: gggacaccagaagtcaacca 
63 81 
Reverse: ggcttggaaccctttatacatc 
TIMP-2 
Forward: aagcggtcagtgagaaggaa 
65 112 
Reverse: tctcaggccctttgaacatc 
TIMP-3 
Forward: gcagcggaccacaacagcta 
68 150 
Reverse: ccggatcacgatgtcggagt 
TIMP-4 
Forward: agggagagcctgaatcatca 
65 68 
Reverse: gcactgcatagcaagtggtg 
uPA 
Forward: cgccacacactgcttcatg 
60 310 
Reverse: ccccttgcgtgttggagtt 
uPAR 
Forward: gcccaatcctggagcttga 
60 63 
Reverse: tccccttgcagctgtaacact 
PAI-1 
Forward: gcacaaccccacaggaaca 
65 81 
Reverse: gtcccgatgaaggcgtcttt 
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Table 2. Relative expression values of mRNAs for some extracellular matrix remodelling 364 
enzymes and their inhibitors in BAEC treated with hydroxytyrosol. 365 
qPCR was carried out as described in Materials and Methods. All qPCR data were 366 
normalized with GAPDH expression levels. Data are given as means±S.D. and they are 367 
percentages of expression taking the corresponding expression values in control, untreated cells 368 
as 100%. 369 
 370 
 371 
372 
 MMP-1 MMP-2 TIMP-1 TIMP-2 TIMP-3 TIMP-4 uPA uPAR 
PAI-
1 
BAEC 16.9 ± 0.5 0.28 ± 0.2 3857.3 ±537.1 
418.0 
±123.9 
14.76 ± 
1.47 
377.6 ± 
209.6 
20.95 ± 
12.1 
2195.8 
± 433.0 
- 
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Table 3. Inhibition of in vivo angiogenesis by hydroxytyrosol (HT) as determined by the 373 
CAM assay. 374 
HT (nmol/CAM) Positive/Total Inhibition (%) 
0 0/8 0 
50 0/6 0 
100 1/8 13 
200 5/12 42 
400 5/8 63 
600 5/7 71 
800 9/10 90 
 375 
376 
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Figure legends 377 
 378 
Fig. 1. Hydroxytyrosol inhibits microvessel outgrowth in the ex vivo rat aortic ring assay.  379 
(A) Representative samples of the aortic ring without or with treatment. (B) Quantification of 380 
the area occupied by new microvessels in controls, controls treated with VEGF and rings treated 381 
with 31.2 µM or 62.5 µM hydroxytyrosol and VEGF. The results are the mean ± SD of three 382 
different assays. 383 
 384 
Fig. 2. Hydroxytyrol inhibits angiogenesis in vivo in the CAM assay. Arrows point rebound 385 
of vessels outward from the treated area. Asterisks indicate disrupted vessels. 386 
 387 
 388 
 389 
 390 
 391 
 392 
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